As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 37 stocks with a net worth of over US$ 445.8 M.
These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Agenus Inc | Pennant Investors Lp | 6.07 | 469,600 | 0.11% | 0.00 | 2.9 M | ||
| Agios Pharmaceuticals Inc | Pennant Investors Lp | 36.07 | 15,100 | 0.03% | 0.00 | 544.7 K | ||
| Allogene Therapeutics Inc | Pennant Investors Lp | 1.19 | 128,400 | 0.06% | -0.01 | 152.8 K | ||
| Altimmune Inc | Pennant Investors Lp | 4.76 | 109,800 | 0.15% | 0.00 | 522.6 K | ||
| Amazon.com Inc. | Pennant Investors Lp | 223.41 | 296,000 | 0.00% | 0.00 | 66.1 M | ||
| Arcturus Therapeutics Holdings Inc | Pennant Investors Lp | 13.78 | 13,100 | 0.05% | 0.00 | 180.5 K | ||
| Arcutis Biotherapeutics Inc | Pennant Investors Lp | 13.82 | 170,900 | 0.15% | 0.00 | 2.4 M | ||
| BioXcel Therapeutics Inc | Pennant Investors Lp | 1.93 | 83,900 | 0.23% | 0.00 | 161.9 K | ||
| Coherus Biosciences Inc | Pennant Investors Lp | 0.81 | 168,100 | 0.15% | 0.00 | 136.2 K | ||
| Compass Therapeutics Inc | Pennant Investors Lp | 2.78 | 199,000 | 0.14% | 0.00 | 553.2 K | ||
| Enanta Pharmaceuticals Inc | Pennant Investors Lp | 7.89 | 35,100 | 0.17% | 0.00 | 276.9 K | ||
| Erasca Inc | Pennant Investors Lp | 1.44 | 166,200 | 0.06% | -0.05 | 239.3 K | ||
| 89bio Inc | Pennant Investors Lp | 10.16 | 44,500 | 0.04% | 0.00 | 452.1 K | ||
| Fate Therapeutics Inc | Pennant Investors Lp | 1.12 | 146,100 | 0.13% | 0.00 | 163.6 K | ||
| FibroGen Inc | Pennant Investors Lp | 5.61 | 768,400 | 0.77% | 0.00 | 4.3 M | ||
| Alphabet Inc - Ordinary Shares - Class A | Pennant Investors Lp | 179.53 | 199,000 | 0.00% | 0.00 | 35.7 M | ||
| IGM Biosciences Inc | Pennant Investors Lp | 1.36 | 64,900 | 0.11% | 0.00 | 88.3 K | ||
| Kalaris Therapeutics Inc. | Pennant Investors Lp | 2.50 | 215,700 | 0.19% | 0.00 | 539.3 K | ||
| Seres Therapeutics Inc | Pennant Investors Lp | 11.87 | 292,300 | 0.19% | 0.00 | 3.5 M | ||
| Macrogenics Inc | Pennant Investors Lp | 1.46 | 43,800 | 0.07% | 0.00 | 63.9 K | ||
| Microsoft Corporation | Pennant Investors Lp | 498.84 | 112,000 | 0.00% | 0.00 | 55.9 M | ||
| Micron Technology Inc. | Pennant Investors Lp | 122.29 | 306,000 | 0.03% | 0.00 | 37.4 M | ||
| Nurix Therapeutics Inc | Pennant Investors Lp | 12.73 | 56,800 | 0.09% | 0.00 | 723.1 K | ||
| Novavax, Inc. | Pennant Investors Lp | 6.80 | 60,300 | 0.04% | -0.01 | 410.0 K | ||
| ODP Corporation (The) | Pennant Investors Lp | 19.66 | 400,000 | 1.19% | 0.09 | 7.9 M | ||
| uniQure N.V. | Pennant Investors Lp | 14.42 | 48,500 | 0.10% | 0.00 | 699.4 K | ||
| Replimune Group Inc | Pennant Investors Lp | 9.40 | 30,500 | 0.04% | -0.01 | 286.7 K | ||
| Relay Therapeutics Inc | Pennant Investors Lp | 3.63 | 42,400 | 0.03% | 0.00 | 153.9 K | ||
| Sage Therapeutics Inc | Pennant Investors Lp | 9.20 | 17,500 | 0.03% | 0.00 | 161 K | ||
| EchoStar Corp - Ordinary Shares - Class A | Pennant Investors Lp | 31.36 | 2,153,209 | 0.79% | 0.00 | 67.5 M | ||
| Zentalis Pharmaceuticals Inc | Pennant Investors Lp | 1.26 | 32,400 | 0.05% | 0.00 | 40.8 K | ||
| Zymeworks BC Inc | Pennant Investors Lp | 13.04 | 38,700 | 0.05% | 0.00 | 504.6 K | ||
| Antero Resources Corp | Pennant Investors Lp | 37.26 | 1,133,000 | 0.36% | 0.07 | 42.2 M | ||
| Enovis Corp | Pennant Investors Lp | 33.65 | 400,000 | 0.73% | NEW | 13.5 M | ||
| Perimeter Solutions SA | Pennant Investors Lp | 15.39 | 2,300,000 | 1.58% | NEW | 35.4 M | ||
| Arcus Biosciences Inc | Pennant Investors Lp | 8.47 | 23,700 | 0.03% | 0.00 | 200.7 K | ||
| Transdigm Group Incorporated | Pennant Investors Lp | 1522.98 | 42,000 | 0.07% | 0.00 | 64.0 M | ||
| Travere Therapeutics Inc | Alan Fournier | 15.01 | - | Investor holds below 1% |